Effects of uric acid on oxidative stress in vascular smooth muscle cells
- Authors:
- Segun Dogru
- Ekrem Yasar
- Akin Yesilkaya
-
Affiliations: Department of Medical Biochemistry, Akdeniz University Medical School, 07058 Antalya, Turkey, Department of Biophysics, Akdeniz University Medical School, 07058 Antalya, Turkey - Published online on: September 18, 2024 https://doi.org/10.3892/br.2024.1859
- Article Number: 171
-
Copyright: © Dogru et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Becker BF: Towards the physiological function of uric acid. Free Radic Biol Med. 14:615–631. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Bardin T and Richette P: Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 26:186–191. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Dalbeth N, Gosling A, Gaffo A and Abhishek A: Gout. Lancet. 397:1843–1855. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J and Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 41:1183–1190. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Feig DI, Kang DH and Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med. 359:1811–1821. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, et al: Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: Potential role in fructose-dependent and-independent fatty liver. J Biol Chem. 287:40732–40744. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Sautin YY, Nakagawa T, Zharikov S and Johnson RJ: Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 293:C584–C596. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Ames BN, Cathcart R, Schwiers E and Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA. 78:6858–6862. 1981.PubMed/NCBI View Article : Google Scholar | |
|
Peden DB, Hohman R, Brown ME, Mason RT, Berkebile C, Fales HM and Kaliner MA: Uric acid is a major antioxidant in human nasal airway secretions. Proc Natl Acad Sci USA. 87:7638–7642. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Sautin YY and Johnson RJ: Uric acid: The oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 27:608–619. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zhao G, Huang L, Song M and Song Y: Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies. Atherosclerosis. 231:61–68. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Zhang W, Iso H, Murakami Y, Miura K, Nagai M, Sugiyama D, Ueshima H and Okamura T: EPOCH-JAPAN GROUP. Serum uric acid and mortality form cardiovascular disease: EPOCH-JAPAN study. J Atheroscler Thromb. 23:692–703. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lee SW, Kim HC, Nam C, Lee HY, Ahn SV, Oh YA and Suh I: Age-differential association between serum uric acid and incident hypertension. Hypertens Res. 42:428–437. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Sakata S, Hata J, Honda T, Hirakawa Y, Oishi E, Shibata M, Yoshida D, Goto K, Kitazono T and Ninomiya T: Serum uric acid levels and cardiovascular mortality in a general Japanese population: The Hisayama study. Hypertens Res. 43:560–568. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kurra V, Vehmas T, Eräranta A, Jokihaara J, Pirttiniemi P, Ruskoaho H, Tokola H, Niemelä O, Mustonen J and Pörsti I: Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency. BMC Nephrol. 16(35)2015.PubMed/NCBI View Article : Google Scholar | |
|
Garcia-Arroyo FE, Gonzaga G, Munoz-Jimenez I, Blas-Marron MG, Silverio O, Tapia E, Soto V, Ranganathan N, Ranganathan P, Vyas U, et al: Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage. PLoS One. 13(e0202901)2018.PubMed/NCBI View Article : Google Scholar | |
|
Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S and Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 38:1101–1106. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Yu MA, Sánchez-Lozada LG, Johnson RJ and Kang DH: Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 28:1234–1242. 2010.PubMed/NCBI | |
|
Hsu WL, Li SY, Liu JS, Huang PH, Lin SJ, Hsu CC, Lin YP and Tarng DC: High uric acid ameliorates indoxyl sulfate-induced endothelial dysfunction and is associated with lower mortality among hemodialysis patients. Toxins (Basel). 9(20)2017.PubMed/NCBI View Article : Google Scholar | |
|
Cai W, Duan XM, Liu Y, Yu J, Tang YL, Liu ZL, Jiang S, Zhang CP, Liu JY and Xu JX: Uric acid induces endothelial dysfunction by activating the HMGB1/RAGE signaling pathway. Biomed Res Int. 2017(4391920)2017.PubMed/NCBI View Article : Google Scholar | |
|
Ko J, Kang HJ, Kim DA, Kim MJ, Ryu ES, Lee S, Ryu JH, Roncal C, Johnson RJ and Kang DH: Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding. FASEB J. 33:13334–13345. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Sandoo A, van Zanten JJ, Metsios GS, Carroll D and Kitas GD: The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 4:302–312. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Brozovich F, Nicholson C, Degen C, Gao YZ, Aggarwal M and Morgan K: Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev. 68:476–532. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A and Montezano AC: Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 114:529–539. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Pacher P, Beckman JS and Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 87:315–424. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Radi R: Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine. Proc Natl Acad Sci USA. 115:5839–5848. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Maruhashi T, Hisatome I, Kihara Y and Higashi Y: Hyperuricemia and endothelial function: From molecular background to clinical perspectives. Atherosclerosis. 278:226–231. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yu W and Cheng JD: Uric acid and cardiovascular disease: An update from molecular mechanism to clinical perspective. Front Pharmacol. 11(582680)2020.PubMed/NCBI View Article : Google Scholar | |
|
Pacher P, Obrosova IG, Mabley JG and Szabó C: Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 12:267–275. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wang F, Yuan Q, Chen F, Pang J, Pan C, Xu F and Chen Y: Fundamental mechanisms of the cell death caused by nitrosative stress. Front Cell Dev Biol. 9(742483)2021.PubMed/NCBI View Article : Google Scholar | |
|
Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, Lee J, Lee MY, Lee SM, Kang DH and Lee BH: Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 28:3197–3204. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Mishima M, Hamada T, Maharani N, Ikeda N, Onohara T, Notsu T, Ninomiya H, Miyazaki S, Mizuta E, Sugihara S, et al: Effects of uric acid on the NO production of HUVECs and its restoration by urate lowering agents. Drug Res (Stuttg). 66:270–274. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lin Y, Xie Y, Hao Z, Bi H, Liu Y, Yang X and Xia Y: Protective effect of uric acid on ox-LDL-induced HUVECs injury via Keap1-Nrf2-ARE pathway. J Immunol Res. 2021(5151168)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ouyang R, Zhao X, Zhang R, Yang J, Li S and Deng D: FGF21 attenuates high uric acid-induced endoplasmic reticulum stress, inflammation and vascular endothelial cell dysfunction by activating Sirt1. Mol Med Rep. 25(35)2022.PubMed/NCBI View Article : Google Scholar | |
|
Li P, Zhang L, Zhang M, Zhou C and Lin N: Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: A mechanism for uric acid-induced endothelial dysfunction. Int J Mol Med. 37:989–997. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Huang Z, Hong Q, Zhang X, Xiao W, Wang L, Cui S, Feng Z, Lv Y, Cai G, Chen X and Wu D: Aldose reductase mediates endothelial cell dysfunction induced by high uric acid concentrations. Cell Commun Signal. 15(3)2017.PubMed/NCBI View Article : Google Scholar | |
|
Lee TS, Lu TM, Chen CH, Guo BC and Hsu CP: Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol. 46(102108)2021.PubMed/NCBI View Article : Google Scholar | |
|
Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H and Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 26:269–275. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Doğru S, Yaşar E and Yeşilkaya A: Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death. J Recept Signal Transduct Res. 42:293–301. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R and Gu W: Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 149:1269–1283. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Itahana Y and Itahana K: Emerging roles of p53 family members in glucose metabolism. Int J Mol Sci. 19(776)2018.PubMed/NCBI View Article : Google Scholar | |
|
Mercer J and Bennett M: The role of p53 in atherosclerosis. Cell Cycle. 5:1907–1909. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Phadwal K, Tang QY, Luijten I, Zhao JF, Corcoran B, Semple RK, Ganley IG and MacRae VE: p53 regulates mitochondrial dynamics in vascular smooth muscle cell calcification. Int J Mol Sci. 24(1643)2023.PubMed/NCBI View Article : Google Scholar | |
|
Popowich DA, Vavra AK, Walsh CP, Bhikhapurwala HA, Rossi NB, Jiang Q, Aalami OO and Kibbe MR: Regulation of reactive oxygen species by p53: Implications for nitric oxide-mediated apoptosis. Am J Physiol Heart Circ Physiol. 298:H2192–H2200. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Itahana Y, Han R, Barbier S, Lei Z, Rozen S and Itahana K: The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene. 34:1799–1810. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, et al: Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 25:425–433. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Oğuz N, Kırça M, Çetin A and Yeşilkaya A: Effect of uric acid on inflammatory COX-2 and ROS pathways in vascular smooth muscle cells. J Recept Signal Transduct Res. 37:500–505. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Tang L, Xu Y, Wei Y and He X: Uric acid induces the expression of TNF-α via the ROS-MAPK-NF-κB signaling pathway in rat vascular smooth muscle cells. Mol Med Rep. 16:6928–6933. 2017.PubMed/NCBI View Article : Google Scholar | |
|
National Research Council: Guide for the Care and Use of Laboratory Animals: 8th edition. The National Academies Press, Washington, DC, 2011. https://doi.org/10.17226/12910. | |
|
American Veterinary Medical Association: AVMA Guidelines for the Euthanasia of Animals. AVMA, Schaumburg, IL, 2020. https://www.avma.org/resources-tools/avma-policies/avma-guidelines-euthanasia-animals. | |
|
Boston University: Institutional animal care and use committee (IACUC) Guidelines. https://www.bu.edu/research/ethics-compliance/. | |
|
University of Maryland: Animal care and use Training. https://research.umd.edu/resources/department-laboratory-animal-resources-dlar/animal-care-and-use-training. | |
|
Ahmadi-Noorbakhsh S, Abbasi MF, Ghasemi M, Bayat G, Davoodian N, Sharif-Paghaleh E, Poormoosavi SM, Rafizadeh M, Maleki M, Shirzad-Aski H, et al: Anesthesia and analgesia for common research models of adult mice. Lab Anim Res. 38(40)2022.PubMed/NCBI View Article : Google Scholar | |
|
Parasuraman S and Christapher PV: Anesthesia and euthanasia of experimental animals. In: Introduction to basics of pharmacology and toxicology: Volume 3: Experimental Pharmacology: Research methodology and biostatistics. Springer, pp65-75, 2022. | |
|
Gunther S, Alexander RW, Atkinson WJ and Gimbrone MA Jr: Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 92:289–298. 1982.PubMed/NCBI View Article : Google Scholar | |
|
Görlach A, Brandes RP, Bassus S, Kronemann N, Kirchmaier CM, Busse R and Schini-Kerth VB: Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 14:1518–1528. 2000.PubMed/NCBI | |
|
Muraoka S and Miura T: Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol Toxicol. 93:284–289. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Rodrigo R, González J and Paoletto F: The role of oxidative stress in the pathophysiology of hypertension. Hyperten Res. 34:431–440. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y and Lu W: The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev. 2021(1470380)2021.PubMed/NCBI View Article : Google Scholar | |
|
Levine AB, Punihaole D and Levine TB: Characterization of the role of nitric oxide and its clinical applications. Cardiology. 122:55–68. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Napoli C, Paolisso G, Casamassimi A, Al-Omran M, Barbieri M, Sommese L, Infante T and Ignarro LJ: Effects of nitric oxide on cell proliferation: Novel insights. J Am Coll Cardiol. 62:89–95. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A and Checherita IA: Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 23(3188)2022.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Qian M, Kyler K and Xu J: Endothelial-vascular smooth muscle cells interactions in atherosclerosis. Front Cardiovasc Med. 5(151)2018.PubMed/NCBI View Article : Google Scholar | |
|
Hirase T and Node K: Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol. 302:H499–H505. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Vanhoutte PM, Zhao Y, Xu A and Leung SW: Thirty years of saying NO: Sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ Res. 119:375–396. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Tsutsui H, Kinugawa S and Matsushima S: Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 30:H2181–H2190. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Sugamura K and Keaney JF Jr: Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 51:978–992. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Drummond GR, Selemidis S, Griendling KK and Sobey CG: Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 10:453–471. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Murray M, Selby-Pham S, Colton BL, Bennett L, Williamson G and Dordevic AL: Does timing of phytonutrient intake influence the suppression of postprandial oxidative stress? A systematic literature review. Redox Biol. 46(102123)2021.PubMed/NCBI View Article : Google Scholar | |
|
Baradaran A, Nasri H and Rafieian-Kopaei M: Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. J Res Med Sci. 19:358–367. 2014.PubMed/NCBI | |
|
Tahhan AS, Sandesara PB, Hayek SS, Alkhoder A, Chivukula K, Hammadah M, Mohamed-Kelli H, O'Neal WT, Topel M, Ghasemzadeh N, et al: Association between oxidative stress and atrial fibrillation. Heart Rhythm. 14:1849–1855. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ahmad KA, Yuan DY, Nawaz W, Ze H, Zhuo CX, Talal B, Taleb A, Mais E and Qilong D: Antioxidant therapy for management of oxidative stress induced hypertension. Free Radic Res. 51:428–438. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kattoor AJ, Pothineni NVK, Palagiri D and Mehta JL: Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 19(42)2017.PubMed/NCBI View Article : Google Scholar | |
|
Dai Y, Cao Y, Zhang Z, Vallurupalli S and Mehta JL: Xanthine oxidase induces foam cell formation through LOX-1 and NLRP3 activation. Cardiovasc Drugs Ther. 31:19–27. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Coliva G, Lange M, Colombo S, Chervet JP, Domingues MR and Fedorova M: Sphingomyelins prevent propagation of lipid peroxidation-LC-MS/MS evaluation of inhibition mechanisms. Molecules. 25(1925)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chan HH, Chan E, Kwok CTK, Leung GPH, Lee SMY and Seto SW: The role of p53 in the alternation of vascular functions. Front Pharmacol. 13(981152)2022.PubMed/NCBI View Article : Google Scholar | |
|
Mercer J, Figg N, Stoneman V, Braganza D and Bennett MR: Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res. 96:667–674. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Cao RY, Eves R, Jia L, Funk CD, Jia Z and Mak AS: Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice. PLoS One. 12(e0175061)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang M and Attardi LD: A balancing act: p53 activity from tumor suppression to pathology and therapeutic implications. Annu Rev Pathol. 17:205–226. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kastenhuber ER and Lowe SW: Putting p53 in context. Cell. 170:1062–1078. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, Govoni S, Buoso E, Racchi M, Barcikowska M, Styczynska M, et al: Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One. 7(e29789)2012.PubMed/NCBI View Article : Google Scholar | |
|
Yang L, Chang B, Guo Y, Wu X and Liu L: The role of oxidative stress-mediated apoptosis in the pathogenesis of uric acid nephropathy. Ren Fail. 41:616–622. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y and Gu W: The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 85:4–32. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kruiswijk F, Labuschagne CF and Vousden KH: p53 in survival, death and metabolic health: A lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 16:393–405. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kibbe MR, Li J, Nie S, Choi BM, Kovesdi I, Lizonova A, Billiar TR and Tzeng E: Potentiation of nitric oxide-induced apoptosis in p53-/- vascular smooth muscle cells. Am J Physiol Cell Physiol. 282:C625–C634. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Kim YM, Choi BM, Kim YS, Kwon YG, Kibbe MR, Billiar TR and Tzeng E: Protective effect of p53 in vascular smooth muscle cells against nitric oxide-induced apoptosis is mediated by up-regulation of heme oxygenase-2. BMB Rep. 41:164–169. 2008.PubMed/NCBI View Article : Google Scholar |
